Table 2.
Top 20 potential SUMO-2/3 targeting TFs before KSHV reactivation
Rank | Name | Transfac | TFBS # (in TSS±500 bp) | Peak # of TFBS (in TSS±500 bp) | % of TFBS Peak (in TSS±500 bp) | Gene # | |||
---|---|---|---|---|---|---|---|---|---|
0 h | 12 h | 0 h | 12 h | 0 h | 12 h | ||||
1 | ETS1 | V$CETS1P54_01 | 1587 | 337 | 397 | 21.2% | 25.0% | 296 | 353 |
2 | GABPA/NRF-2 | V$NRF2_01 | 1577 | 320 | 379 | 20.3% | 24.0% | 274 | 335 |
3 | ELK1 | V$ELK1_02 | 1667 | 336 | 382 | 20.2% | 22.9% | 285 | 328 |
4 | STAT4 | V$STAT4_01 | 106 | 20 | 12 | 18.9% | 11.3% | 7 | 12 |
5 | STAT1 | V$STAT1_03 | 282 | 53 | 79 | 18.8% | 28.0% | 45 | 68 |
6 | CREB1 | V$CREB_01 | 666 | 124 | 164 | 18.6% | 24.6% | 114 | 152 |
7 | ATF2 | V$CREBP1_01 | 272 | 45 | 67 | 16.5% | 24.6% | 45 | 64 |
V$CREBP1_Q2 | 1273 | 168 | 201 | 13.2% | 15.8% | 135 | 198 | ||
8 | STAT6 | V$STAT_01 | 570 | 92 | 122 | 16.1% | 21.4% | 85 | 110 |
9 | MYC/MAX | V$MYCMAX_02 | 580 | 93 | 96 | 16.0% | 16.6% | 74 | 87 |
10 | MAX | V$MAX_01 | 584 | 93 | 110 | 15.9% | 18.8% | 79 | 97 |
11 | HLF | V$HLF_01 | 438 | 69 | 90 | 15.8% | 20.5% | 66 | 85 |
12 | USF1 | V$USF_C | 441 | 69 | 86 | 15.6% | 19.5% | 64 | 78 |
13 | ARID5B/MRF2 | V$MRF2_01 | 478 | 74 | 100 | 15.5% | 20.9% | 68 | 91 |
14 | NFYA/B/C | V$NFY_Q6 | 1557 | 217 | 295 | 13.9% | 18.9% | 176 | 250 |
V$NFY_C | 416 | 57 | 79 | 13.7% | 19.0% | 55 | 75 | ||
15 | SREBF1/SREBP1 | V$SREBP1_01 | 1038 | 144 | 179 | 13.9% | 17.2% | 100 | 170 |
16 | STAT5A | V$STAT5A_02 | 982 | 135 | 155 | 13.7% | 15.8% | 109 | 133 |
17 | ZEB1 | V$AREB6_04 | 530 | 70 | 89 | 13.2% | 16.8% | 60 | 78 |
18 | ARNT | V$ARNT_01 | 835 | 110 | 136 | 13.2% | 16.3% | 106 | 131 |
19 | E2F1/2/3/4/5 | V$E2F_02 | 1301 | 171 | 226 | 13.1% | 17.4% | 155 | 199 |
20 | STAT3 | V$STAT3_01 | 986 | 129 | 168 | 13.1% | 17.0% | 127 | 159 |
bold: transcription factor with evidence of SUMO modification.